- Press Releases
- 09.20.2022
Enclara Pharmacia Announces Appointment of New Vice President of Business Development
PHILADELPHIA – September 20, 2022 – Enclara Pharmacia, the market leader in comprehensive pharmacy management services to the hospice community, has announced the appointment of...
- Blog
- 09.01.2022
Time Saving Medication Management + NHPCO IDC
Enclara Pharmacia is proud to be a Bronze Level Sponsor of this year’s NHPCO Virtual Interdisciplinary Conference. This year, the conference is focusing on workforce...
- Blog
- 07.21.2022
The Top Five Dietary Supplements Among American Seniors: Do They Have a Role in Hospice Care?
Dietary supplements are big business in the USA. Three out of four Americans aged 60 or older take at least one supplement. These supplements are...
- Blog
- 06.16.2022
Addressing Five Major Barriers to Hospice Utilization in the LGBTQ+ Community
In the 1970s and 1980s, members of the LGBTQ+ community fought for their rights and helped build a society in which they could be “out...
- Blog
- 06.13.2022
Enclara Trainers Gear Up for Launch of E3 Pro Hospice Medication Management App
When Enclara Pharmacia launched its E3 MobileTM application in 2017, most hospice nurses were used to calling in patient prescriptions. The new application allowed nurses...
- Blog
- 04.29.2022
Evaluating Five of the Most Common Complementary Therapies in Hospice Care
Therapeutic alternatives to conventional Western medicine have long been a staple of many hospice programs due to their shared focus on comfort and quality of...
- Blog
- 04.01.2022
Drug Shortages Continue to Impact Hospice Providers in 2022
Over the last two years, Americans have become increasingly familiar with the concept of supply chains and just how fragile they can be. Of course,...
- Blog
- 03.30.2022
Enclara in the News: Ealia Washington, PharmD, CGP, BCACP Sits Down With Hospice News
In this Voices interview, our Senior Director of IPU Operations, Ealia Washington, PharmD, CGP, BCACP, sits down with Hospice News to learn the ins and...